September 07, 2026 07:03 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘No one can dictate what Bengalis eat’: BJP’s blunt message amid Bageshwar Baba’s Durga Puja food row | Delhi hostel collapse: Owner detained after seven die in Satya Niketan tragedy | No Muslims, Aadhaar card and tilak mandatory: VHP lays down rules for Garba, Dandiya in Maharashtra | 'No non-veg near Durga Puja pandals': Bageshwar Baba's big Bengal appeal sparks controversy | 'Law will take its action': Vijay's zero tolerance on insulting women weeks after Udhayanidhi's arrest | Delhi Metro's big warning to content creators: Don't try this viral stunt or face action | Hindutva influencer Swatantra Bhardwaj detained after viral assault clip; Chirag Paswan’s party files complaint for ‘falsely’ naming him | Bengaluru horror: Woman stripped, assaulted and filmed over unpaid loan interest; 4 arrested | West Bengal CM's big warning: Teacher suspended over tilak row, govt employee punished for PM Modi post | Tragedy on Kerala Highway: 8 Tamil Nadu students killed after car crashes into parked lorry

Migraine treatment injection from Dr Reddy's Lab now available in the US

| | Apr 19, 2016, at 08:22 pm
Hyderabad/Princeton-NJ, Apr 19 (IBNS) Promius Pharma LLC, a subsidiary of Dr. Reddy's Laboratories Ltd, has informed on Tuesday that its ZEMBRACE SymTouch (sumatriptan injection) 3 mg, which was approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
The company said that ZEMBRACE SymTouch is a pre filled, low-dose, ready-to-use, 2-step autoinjector containing 3 mg of sumatriptan, a selective 5-HT1B/ID receptor agonist. Because ZEMBRACE SymTouch is a subcutaneous injection, it may lead to rapid relief of migraine.

 

Migraineurs often have more than one kind of attack. Different types of medications can be used to treat different types of attacks. 
 
According to Roger Cady, MD, Associate Executive Chairman of the National Headache Foundation “ZEMBRACE SymTouch is a welcome addition to the toolkit for acute treatment of migraine. This 3-mg, easy to-use subcutaneous injection of sumatriptan may be desired by many migraine patients who need a medication that can rapidly treat migraine attacks. Also, the 3-mg dose allows for up to 4 doses of ZEMBRACE SymTouch in a 24-hour period, thus allowing dosing flexibility for patients.” 
 
ZEMBRACE SymTouch is available as a box of 4 autoinjectors.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.